Pegasystems Q2 2026: Revenue Climbs 9%, but Legal Costs and AI Headwinds Pressure Profits
PEGA is trading near its 52-week low of $28.66 (0.4% above the low) on elevated volume (2.4× avg).
Summary
Pegasystems' Q2 revenue grew 9% to $420.7M, but net income dropped 56% to $13.3M as legal costs surged. The Appian litigation remains a major risk with a $2.33B counterclaim, while AI disruption slows ACV growth. The company bought back $367M in stock at an average price of $41.46, well above the current $28.77.
Key Events · Earnings and Guidance · PEGA
-
Revenue Up 9%, Cloud Surges
Q2 2026 revenue reached $420.7 million, up 9% year-over-year, with Pega Cloud revenue jumping 28% to $213.9 million. Subscription services grew 17% to $288.5 million.
-
Net Income Plunges on Legal Costs
Net income fell to $13.3 million from $30.1 million in Q2 2025, a 56% decline, as general and administrative expenses surged 38% to $43.7 million due to higher legal fees from Appian litigation.
-
AI Disruption Slows ACV Growth
Annual contract value (ACV) growth slowed to 7% (8% constant currency) as clients delayed purchasing decisions amid AI market changes. Management expects this headwind to persist.
-
Appian Litigation: $2.33B Counterclaim Overhang
Appian's defamation counterclaims seek $2.33 billion in disgorgement of Pegasystems' profits from 2022-2025. The trade secret retrial is set for January 11, 2027. The derivative suit was settled for $9.75 million.
Analysis · PEGA · Technology
Top-line momentum remained intact as revenue rose 9% to $420.7 million, fueled by a 28% surge in Pega Cloud. Yet the bottom line told a different story: net income tumbled to $13.3 million from $30.1 million a year ago, largely because general and administrative costs jumped 38% on escalating legal fees tied to the Appian dispute. Adding to the uncertainty, management flagged that AI-driven market disruption is slowing ACV growth—a headwind expected to persist. On the litigation front, the derivative suit was settled for $9.75 million, but the Appian trade secret retrial is now set for January 2027, and Appian's defamation counterclaims seek $2.33 billion in disgorgement, a massive overhang. Meanwhile, the company repurchased $367 million in stock at an average price of $41.46, well above today's $28.77, signaling management conviction but also consuming cash. With the stock near its 52-week low, the market is pricing in significant litigation risk and growth uncertainty.
At the time of this filing, PEGA was trading at $28.77 on NASDAQ in the Technology sector, with a market capitalization of approximately $5.2B. The 52-week trading range was $28.66 to $68.10. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.